Jullian joined Lilly in October of 2016. As Senior Director of Oncology Business Development, Search & Evaluation for Lilly, Jullian’s team is responsible for the strategic and technical assessment of external, in-licensing and M&A oncology opportunities across the clinical and preclinical portfolio as well as leading outlicensing for Lilly Research Labs and Oncology Business Unit.
Prior to Lilly, Jullian performed several leadership roles at Boehringer Ingelheim, including co-leading the strategic and technical assessment of external, in-licensing opportunities for their clinical oncology business development group. At BI, Jullian also led roles in pipeline products (new product planning) and marketing.
Jullian began her life sciences business development career at Columbia Technology Ventures (CTV), where for several years she led the out-licensing, commercialization and strategic partnerships across a portfolio consisting pre-clinical life science, biotechnology, therapeutic, diagnostic and medical technologies. At CTV, Jullian was also responsible for facilitating the spin-off of early-phase companies.
Jullian has a Ph.D. from the Johns Hopkins University; a J.D. from Georgetown Law Center; and an M.B.A. from Columbia University.